U.S. markets closed

Abcam plc (ABCM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.47-0.63 (-3.30%)
At close: 4:00PM EDT

Abcam plc

Discovery Drive
Cambridge Biomedical Campus
Cambridge CB2 0AX
United Kingdom
44 1223 696 000
http://www.abcam.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees1,600

Key Executives

NameTitlePayExercisedYear Born
Mr. Alan Thomas Hirzel BS, MS, MBACEO & Exec. Director1.49MN/A1968
Mr. Michael Shaun BaldockCFO & Director749.15kN/A1964
Mr. Mark DermodyInterim CION/AN/AN/A
James StaveleyVP of Investor RelationsN/AN/AN/A
Marc PerkinsGen. Counsel & Company Sec.N/AN/AN/A
Dr. Cheri L. WalkerSr. VP of Corp. Devel.N/AN/AN/A
Mr. Nick SkinnerSr. VP of HRN/AN/AN/A
Mr. Mark BushfieldSr. VP of Research & InnovationN/AN/AN/A
Ms. Kirstie Speck BBusScHead of Consumer InsightsN/AN/AN/A
Ms. Yvonne ChienSr. VP of Customer ExperienceN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Corporate Governance

Abcam plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.